CASP3 and Alzheimer disease: Caspase-3 gene expression—a biomarker of apoptotic cell death—was reduced with nilotinib treatment [6], consistent with volumetric magnetic resonance imaging (vMRI), showing reduced hippocampal atrophy in nilotinib-treated AD patients [4].